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Abstract Introduction. Gastrointestinal stromal tumors (GISTs) represent a rare type of gastrointestinal 
neoplasms. Resection with negative margins has been established as a mainstay treatment, but 
laparoscopic resections are still open to debate. Material and method. This retrospective study was 
conducted at a single institution, with data collected over 2 years (01.01.2017-01.01.2019). The 
variables examined were age, tumor location with regard to the gastric wall, the results of the 
intraoperative endoscopy, intraoperative and postoperative complications, the surgical technique, 
and histopathological reports.  Results. We identified 12 relevant cases, of which 8 were females 
and 4 males. The average tumor diameter was 2.3 cm. The majority of the lesions were located on 
the anterior gastric wall (8 cases), on the small curvature (2 cases), and in the pyloric region (2 
cases). Intraoperative endoscopy was performed successfully in 10 cases in order to identify the 
lesions and guide the resection. The average operative time was 120 minutes and the average 
hospital stay was 5 days. The gastric wall with the lesion was resected using an Ultrasonic device, 
a 2-cm oncological safety margin was preserved. Conclusion. Complete surgical resection 
independent from the tumor size represents the current optimal treatment. From a surgical point of 
view, these tumors must be considered malignant and the surgeon must respect principles of 
oncological surgery. Maintaining tumor integrity at dissection is critical for the patient’s long-term 
prognosis. Laparoscopic resection independent of the tumor size is feasible. 
Keywords  GIST, gastric, laparoscopy, technique 
Highlights ✓ Complete surgical resection independent of tumor size represents the current optimal 
treatment of GISTs. 
✓ Laparoscopic resection is possible, although the surgeon’s experience along with careful 
patient selection plays a critical role. 
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Introduction 
Mesenchymal gastrointestinal tumors or GISTs are a 
particular subtype of gastrointestinal tumors (1). Although 
these tumors have historically been considered benign or 
borderline malignant, with the recent evolution of 
immunohistochemical and histopathological diagnostic 
methods, GISTs have been redefined as malignant tumors, 
meaning that the oncological principles of resection must 
be respected (2). 
Regarding their location, these tumors can develop 
anywhere in the gastrointestinal tract but are most 
commonly identified at the gastric level in up to 60% of the 
cases. The stomach is more accessible for endoscopy than 
the small intestine which this may account for its increased 
incidence (3). Another cause may be the embryological 
origin of these tumors that evolve from the Cajal cells – 
which represent the pacemaker of the digestive tract 
located at the level of the gastric fornix (3). 
The degree of malignancy of these tumors is given by 
the tumor macroscopic characteristics (size), but also by 
the cells themselves, i.e. the number and frequency of 
mitoses, or the degree of differentiation (4). 
Taking these factors into consideration, the surgeon 
must avoid rupturing the tumor capsule during surgery and 
maintain negative resection margins of 1-2 cm. 
Lymphadenectomy is not required when a GIST tumor is 
identified, since tumor cells rarely disseminate through the 
lymphatic system (5). Given these recommendations, if a 
gastric GIST is confirmed, a wedge resection can be 
performed – which is a straight-forward intervention. Since 
laparoscopy has evolved and increasingly complex 
interventions are now being performed, the question 
regarding the application of this technique to gastric GISTs 
has arisen. (6). Several authors such as Joensuu et al. and 
Nguyen et al. have confirmed the feasibility of this 
intervention, which implies a full-thickness resection of the 
gastric wall through a minimally invasive approach (7, 8). 
Also, a large-scale meta-analysis has been published, 
which confirms the aforementioned results (9, 10). 
Regarding the size of the tumors, laparoscopy has been 
recommended only for tumors under 2 cm due to the high 
risk of rupture and contamination at dissection, but this 
approach has not been supported by all authors. De 
Vogelaere et al. demonstrated, on a group of 31 patients, 
that the size of the tumor does not impact the relapse rate 
for laparoscopic operations (11, 12).  
Our study aimed to reevaluate the oncological outcome 
and technique when resecting gastric GISTs, based on 
experience from our clinic. Due to widespread endoscopic 
evaluations, gastric tumors are identified in the early stages 
limited to the submucosa, with no expression at the level 
of the serosa. Thus, they are difficult to identify and resect 
using oncological safety margins. Through this study, we 
aimed to evaluate the use of intraoperative endoscopy in 
order to identify these tumors and guide the resection 
process. 
Materials and Methods 
The study is a retrospective analysis conducted in a 
single institution, with data obtained over a 2-year period 
(01.01.2017-01.01.2019). Variables examined were age, 
tumor location with regard to the gastric wall, results of the 
intraoperative endoscopy, intraoperative and postoperative 
complications, surgical technique, and histopathological 
reports. In addition, the efficacy of the intraoperative 
endoscopical procedure in identifying the tumors and 
guiding the resection was evaluated. The results of the 1-
year evaluation, which included a CT with contrast media 
and upper endoscopy, were also examined. All patients 
were operated on laparoscopically. Tumor size did not 
represent a contraindication.  
Results 
We identified 12 cases, of which 8 were females and 4 
males. Age at diagnosis ranged between 32 and 64 years. 
Common symptoms were gastric bleeding, anemia, and 
weight loss.  
 
Figure 1. Large GIST (8cm) located on the anterior 
gastric wall (arrow). 
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Figure 2. Small gastric GIST (circle) located 
between the mucosal folds of the stomach, 
identified through intraoperative endoscopy. 
 
Figure 3. An aspect of gastrotomy after the 
resection of a GIST identified through the 
preoperative endoscopic instillation of methylene 
blue. 
 
Figure 4. The aspect of a large gastric GIST after 
resection with safety margins of 2 cm. The surface 
is round, smooth with no macroscopic signs of 
invasion.   
The average tumor diameter was 2.3 cm, with a 
maximum of 15 cm and a minimum of 1.7 cm (Figure no. 
4). Gastrostomy has always been sutured with a double 
layer Vicryl wire. The integrity of the suture line was 
verified intraoperatively with the use of methylene blue, 
which was administered through the nasogastric tube. 
The intraoperative laparoscopic exploration did not 
reveal peritoneal metastasis, which correlated with the 
preoperative investigations. Regarding the location of the 
tumor, the majority of the lesions were located on the 
anterior gastric wall (8 cases), on the small curvature (2 
cases), and in the pyloric region (2 cases). Some of the 
tumors were large and had an important expression on the 
level of the gastric serosa which made them easily 
identifiable, as seen in Figure 1. In other cases, the tumors 
were limited to the submucosa, thus being nearly 
impossible to identify laparoscopically. Frequently, tumors 
are located between the gastric mucosal folds. In such 
cases, intraoperative endoscopy is very helpful.  
In our series, intraoperative endoscopy was performed 
successfully in 10 cases in order to identify the lesions and 
guide the resection (Figure no. 1). In 4 cases, preoperative 
endoscopic staining was used to identify the lesion (Figure 
no 2). Endoscopy proved helpful in identifying the small 
lesions located in the submucosa, which had no expression 
at the level of the serosa. 
Great care was taken at dissection to avoid 
intraoperative tumor ruptures. The average operative time 
was 120 minutes, but depended on whether gastric suture 
was done with a stapler or manually. All patients had a 
contrast barium Rx on the third day to identify any 
potential leakage. There was none. 
All patients had a drainage tube placed in the Morisson 
pouch and which was removed on the second postoperative 
day, with no complications. The average hospital stay was 
5 days. All patients had a nasogastric tube placed 
intraoperatively which was removed on the third day. The 
gastric wall with the lesion was resected using an 
Ultrasonic device, with a 2-cm oncological safety margin. 
All resections were R0. A one-year reevaluation through 
endoscopy and CT did not reveal any sign of relapse. 
Regarding the postoperative complications, we 
encountered one case of intraluminal bleeding, which was 
terminated with clips applied endoscopically on the third 
postoperative day. 
Discussions 
The first description of a gastrointestinal stromal tumor 
was published in 1983 by Clar and Mazur who defined it 
as a new type of sarcoma (13). Although GISTs were 
Iulian Slavu et al. 
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initially considered benign, they are now considered 
malignant, although they rarely have a diffuse infiltrating 
evolution in the organs in which they originate. These 
tumors rarely lead to lymphatic metastasis (14, 15).  
Due to these characteristics, local excision is 
considered sufficient as a final treatment. Some authors 
even recommend enucleation for small tumors. We, 
however, do not recommend this technique in laparoscopy 
due to the rigidity of the instruments which may perforate 
and disseminate the tumor cells in the peritoneal cavity. 
Rupturing the capsule of the tumor can have catastrophic 
results for the patient, so one should avoid manipulating 
the tumor directly during surgery and should grasp only the 
tissue around the tumor. Also, an endo-bag is mandatory 
when extracting the specimen so as not to contaminate the 
abdominal wall (16). 
As demonstrated in our series of patients, a 
laparoscopic wedge resection is technically feasible, 
ensuring good oncological results without affecting the 
functionality of the gastric tube (17). Due to the constant 
advancements in stapler technology and laparoscopic 
gastric surgery, this technique has also been recommended 
by other authors (18, 19). However, depending on the 
tumor location, this technique is not always feasible; small 
tumors located on the anterior gastric wall are usually ideal 
for this resection. In our series, when a wedge resection 
could not be performed, a gastric wall resection using an 
ultrasonic device with subsequent suturing of the defect 
using a double layer, resorbable running suture gave the 
best results with no postoperative complications. It did, 
however, extend operative time considerably. 
Regarding the size of the tumors, past practice avoided 
laparoscopy when tumor size exceeded 2 cm (20). From 
our standpoint, if the laparoscopic instruments are 
available and the surgeon has the necessary experience, the 
size of the tumor should not represent a contraindication 
for laparoscopy. As demonstrated in our study, tumors up 
to 8-10 cm were resected laparoscopically with good 
oncological and functional outcomes. Multiple studies in 
the literature have confirmed its feasibility, although the 
NCCN guidelines and the European ESMO guidelines do 
not recommend laparoscopy for resection of large GIST 
tumors (21).   Consistent with our perspective, Ye et al. 
also note that the surgeon’s experience is paramount when 
selecting to laparoscopically operate on a GIST in order to 
avoid capsule tears and peritoneal spillage of the tumor 
cells (22). Perhaps in the near future, the guidelines will 
adapt to the experience gained by surgeons in the field of 
laparoscopy (23-25). 
Some studies have shown good results with hand-
assisted laparoscopic resections, to gently manipulate the 
tumor and dissect it from the surrounding structures. This 
technique was not used on the patients in our series since 
the tumors were dissected safely only with the laparoscopic 
instruments. Regarding the oncological safety margins, our 
resections involve a 1-2cm distance from the tumor, 
although research has demonstrated that the rate of 
recurrence does not seem to be influenced by the resection 
distance and varies rather according to the size of the 
tumor. Keeping these aspects in mind, the surgeon must 
obtain a clear macroscopic resection without 
lymphadenectomy (26). Although our sample size was 
small, our group had a postoperative survival rate of 100 % 
at 1 year. 
When smaller tumors are encountered, intraoperative 
endoscopy is helpful in guiding the surgeon to the location 
of the lesion. For example, we encountered gastric 
submucosal tumors of 1-2cm, with no clear expression at 
the level of the serosa. Endoscopy is paramount in these 
situations. If one does not identify the lesion, the use of 
staples should be avoided and a circumferential resection 
under the direct guidance of the endoscopist is 
recommended to avoid the rupture of the tumor with 
subsequent spillage. In four cases, we used the preoperative 
marking of the lesion with methylene blue, but the 
endoscopist had to pay close attention to the depth of the 
gastric layers and the quantity when administering the 
substance, since it can always dissipate in a large area of 
the gastric wall (27, 28). This makes it difficult for the 
surgeon to correctly resect the area where the tumor is 
located. 
Protocols for postoperative monitoring are open to 
discussion, since the frequency and the instruments used 
vary according to several criteria. Recent data tend to 
ignore absolute definitions of benign or malignant. 
Moreover, we noticed that this field is continuously 
changing (29): the tumors were initially defined as benign, 
then malignant, and now benign or malignant, with 
differentiating factors being their size (above 10 cm) and 
rate of division (30). A high index of replication increases 
the mortality rate of up to 50% when compared to low 
mitotic tumors (30). 
A high mitotic index is defined as 10 mitoses per 50 
HPF (high power fields), and this index predicts the 
recurrence rate. Thus, due to the ongoing redefinition of 
these tumors and reclassifications, no clear follow-up 
protocol has been standardized. Therefore, since these 
tumors have an unpredictable evolution, long-term 
monitoring is crucial, from our point of view. After 
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surgery, we evaluated the patients at 6 months when 
endoscopy was done, with an annual CT of the thorax, 
abdomen, and pelvis in the first 2 years. Nowain et al. noted 
that most recurrences usually evolved within this time 
period (31).  
The global overall survival at 5 years after laparoscopic 
resection reaches 92%-93%, while the 3-year survival rate 
is 96% after the laparoscopic resection (32).  
Conclusions 
Knowledge regarding GISTs is continuously evolving. 
Complete surgical resection independent of tumor size 
represents the current optimal treatment. These tumors 
must be considered malignant from a surgical standpoint 
and the surgeon must respect the oncological surgery 
principles.  
Maintaining tumor integrity at dissection is critical for 
the patient’s long-term prognosis. Laparoscopic resection 
independent of the tumor size is possible, although the 
surgeon’s experience along with careful patient selection 
plays a critical role. Currently, no clear post-operative 
follow-up protocol exists, but long-term survival is good. 
The rate of tumor relapse varies according to the tumor size 
and mitotic index. 
Conflict of interest disclosure 
There are no known conflicts of interest in the 
publication of this article. The manuscript was read and 
approved by all authors. 
Compliance with ethical standards 
Any aspect of the work covered in this manuscript has 
been conducted with the ethical approval of all relevant 
bodies and that such approvals are acknowledged within 
the manuscript. 
References 
1. Corless CL, Fletcher JA, Heinrich MC. Biology of 
gastrointestinal stromal tumors. J Clin Oncol. 2004; 
22(18): 3813–3825. 
2. Nowain A, Bhakta H, Pais S, et al. Gastrointestinal 
stromal tumors: clinical profile, pathogenesis, 
treatment strategies and prognosis. J Gastroenterol 
Hepatol. 2005; 20: 818–824. 
3. Sircar K, Hewlett BR, Huizinga JD, Chorneyko K, 
Berezin I, Riddell RH. Interstitial cells of Cajal as 
precursors of gastrointestinal stromal tumors. Am J 
Surg Pathol. 1999; 23(4): 377–89. 
4. Lai IR, Lee WJ, SC Y. Minimally invasive surgery for 
gastric stromal cell tumors: intermediate follow-up 
results. J Gastrointest Surg. 2006; 10(4): 563–6. 
5. Yang J, Feng F, Li M, Sun L, Hong L, Cai L, Wang W, 
Xu G, Zhang H. Surgical resection should be taken into 
consideration for the treatment of small gastric 
gastrointestinal stromal tumors. Word J Surg Oncol. 
2013; 11: 273. DOI: 10.1186/1477-7819-11-273 
6. Lin J, Huang C, Zheng C, Li P, Xie J, Wang J, Lu J. 
Laparoscopic versus open gastric resection for larger 
than 5 cm primary gastric gastrointestinal stromal 
tumors (GIST): a size-matched comparison. Surg 
Endosc. 2014; 28(9): 2577–83. 
7. Joensuu H, Fletcher C, Dimitrijevic S, Silberman S, 
Roberts P, Demetri G. Management of malignant 
gastrointestinal stromal tumours. Lancet Oncol. 2002; 
3(11): 655-64. 
8. Nguyen NT, Jim J, Nguyen A, Lee J, Chang K. 
Laparoscopic resection of gastric stromal tumor: a 
tailored approach. Am Surg. 2003; 69(11): 946–950. 
9. Koh YX, Chok AY, Zheng HL, Tan CS, Chow PK, 
Wong WK, Goh BK. A systematic review and meta-
analysis comparing laparoscopic versus open gastric 
resections for gastrointestinal stromal tumors of the 
stomach. Ann Surg Oncol. 2013; 20(11): 3549–60. 
10. Liang JW, Zheng ZC, Zhang JJ, Zhang T, Zhao Y, 
Yang W, Liu YQ. Laparoscopic versus open gastric 
resections for gastric gastrointestinal stromal tumors: a 
meta-analysis. Surg Laparosc Endosc Percutan Tech. 
2013; 23(4): 378–87. 
11. De Vogelaere K1, Van Loo I, Peters O, Hoorens A, 
Haentjens P, Delvaux G. Laparoscopic resection of 
gastric gastrointestinal stromal tumors (GIST) is safe 
and effective, irrespective of tumor size. Surg Endosc. 
2012; 26(8): 2339–2345. 
12. Matthews BD, Walsh RM, Kercher KW, et al. 
Laparoscopic vs open resection of gastric stromal 
tumors. Surg Endosc. 2002; 16(5): 803–807.  
13. Mazur MT, Clark HB. Gastric stromal tumors: 
reappraisal of histogenesis. Am J Surg Pathol. 1983; 
7(6): 507–519. 
14. Bolocan A, Paduraru DN, Nitipir C, et al. Mixed 
adenoneuroendocrine carcinoma of the gastrointestinal 
tract-features, diagnosis, management and prognostics. 
Romanian Biotechnological Letters. 2018; 23(6): 
14193-14202.    
15. Ng EH, Pollock RE, Munsell MF, et al. Prognostic 
factors influencing survival in gastrointestinal 
leiomyosarcomas: implications for surgical 
management and staging. Ann Surg. 1992; 215(1): 68 –
77.  
Iulian Slavu et al. 
 339 
16. Kong SH, Yang HK. Surgical Treatment of Gastric 
Gastrointestinal Stromal Tumor. J Gastric Cancer. 
2013; 13(1): 3-18. 
17. Heinrich MC, Corless CL. Gastric GI stromal tumors 
(GISTs): the role of surgery in the era of targeted 
therapy. J Surg Oncol. 2005; 90(3): 195– 207; 
discussion 207. 
18. Yoshida M, Otani Y, Ohgami M, et al. Surgical 
management of gastric leiomyosarcoma: evaluation of 
the propriety of laparoscopic wedge resection. World J 
Surg. 1997; 21(4): 440–443.  
19. Heinrich MC, Corless CL. Gastric GI stromal tumors 
(GISTs): the role of surgery in the era of targeted 
therapy. J Surg Oncol. 2005; 90(3): 195–207. 
20. Gastrointestinal stromal tumours. ESMO clinical 
practice guidelines for diagnosis, treatment and follow-
up. Ann Oncol. 2014; 25 Suppl 3: iii21-6. DOI: 
10.1093/annonc/mdu255. 
21. Ye L, Wu X, Wu T, Wu Q, Liu Z, Liu C, Li S, Chen T. 
Meta-analysis of laparoscopic vs. open resection of 
gastric gastrointestinal stromal tumors. PLoS One. 
2017; 12(5): e177193. 
22. Otani Y, Furukawa T, Yoshida M, Saikawa Y, Wada 
N, Ueda M, Kubota T, Mukai M, Kameyama K, Sugino 
Y, Kumai K, Kitajima M. Operative indications for 
relatively small (2–5 cm) gastrointestinal stromal tumor 
of the stomach based on analysis of 60 operated cases. 
Surgery. 2006; 139(4): 484–492. 
23. Catena F, Di Battista M, Fusaroli P, Ansaloni L, Di 
Scioscio V, Santini D, Pantaleo M, Biasco G, Caletti G, 
Pinna A. Laparoscopic treatment of gastric GIST: 
report of 21 cases and literature’s review. J Gastrointest 
Surg. 2008; 12(3): 561–568. 
24. Novitsky YW Kercher KW, Sing RFDO, Todd 
Heniford B. Long-term outcomes of laparoscopic 
resection of gastric gastrointestinal stromal tumors. 
Ann Surg. 2006; 243: 738–745. 
25. DeMatteo RP, Lewis JJ, Leung D, et al. Two hundred 
gastrointestinal stromal tumors: recurrence patterns and 
prognostic factors for survival. Ann Surg. 2000; 231(1): 
51–58. 
26. Stefanescu DC, Ciucu AA, Rabinca AA, et al. An 
integrative medical perspective on novel dopamine 
detection. Rev Chim. (Bucharest) 2018; 69(1): 277-
281. 
27. Hainarosie R, Zainea V, Hainarosie M,et al. Methylene 
Blue Test in Assessing Disease Free Margins in 
Lingual Carcinoma Resection. Rev Chim. (Bucharest). 
2017; 68(12): 2879-2880. 
28. Ciocirlan M, Draghia L, Manuc D, et al. Nutritional 
status of patients with digestive cancers. Conference: 
3rd International Conference on Interdisciplinary 
Management of Diabetes Mellitus and its 
Complications (INTERDIAB) Location: Bucharest, 
ROMANIA Date: MAR 02-04, 2017Sponsor(s): Assoc 
Renal Metab & Nutrit Studies; AstraZeneca Diabetes; 
MSD Diabetes; novo nordisk; SANOFI INTERDIAB 
2017: DIABETES MELLITUS IN INTERNAL 
MEDICINE   Book Series: International Conference on 
Interdisciplinary Management of Diabetes Mellitus and 
its Complications. 2017: 132-138.    
29. Miettinen M, Sobin LH, Lasota J. Gastrointestinal 
stromal tumors of the stomach: a clinicopathologic, 
immunohistochemical, and molecular genetic study of 
1765 cases with long-term follow-up. Am J Surg 
Pathol. 2005; 29(1): 52–68. 
30. Poesina ND, Bălălău C, Bârcă M, Ion I, Baconi D, 
Baston C, Băran Poesina V. Testicular 
histopathological changes following sodium fluoride 
administration in mice. Rom J Morphol Embryol. 2013; 
54(4): 1019-24. 
31. Novitsky YW, Kercher KW, Sing RF, Heniford BT. 
Long-term Outcomes of Laparoscopic Resection of 
Gastric Gastrointestinal Stromal Tumors. Ann Surg. 
2006; 243(6): 738–747. 
32. Fujimoto Y, Nakanishi Y, Yoshimura K, et al. 
Clinicopathologic study of primary malignant 
gastrointestinal stromal tumor of the stomach, with 
special reference to prognostic factors: analysis of 
results in 140 surgically resected patients. Gastric 
Cancer. 2003; 6(1): 39–48. 
 
 
